MARKETS
Markets

bioAffinity Enters Into Distribution Agreement With AvMEDICAL Expanding bioAffinity's Commercial Reach Through AvMEDICAL's Existing Sales Team

Aug 18, 2026 · 08:06 AM ET· updated 1h ago

New partner’s national sales force will market CyPath Lung to federal healthcare agencies, including VA medical centers nationwideAgreement significantly expands bioAffinity's commercial reach through

Share
Why It Matters

bioAffinity found a partner with an existing sales team to help sell their lung-testing product to hospitals and government health centers across the country. This is like hiring someone who already knows lots of doctors instead of starting from scratch—watch to see if more hospitals actually start using their product.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.